As of Jul 28
| +0.14 / +2.82%|
The 2 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 17.50, with a high estimate of 19.00 and a low estimate of 16.00. The median estimate represents a +242.47% increase from the last price of 5.11.
The current consensus among 2 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.